Home : Unsafe Drugs : Aredia
Aredia
Aredia is a common bisphosphonate, manufactured by Novartis, and is usually used to treat hypocalcaemia, Paget's disease, and cancer. In late 2005, the FDA announced that Aredia may contribute to a serious degenerative bone disease known as Osteonecrosis of the Jaw (ONJ). The FDA warned doctors and patients to avoid serious dental procedures while on Aredia because of the possibility of developing ONJ. Common side effects of ONJ include loose teeth, loss of teeth, bleeding or sore gums, exposed bone and excess drainage from the jaw.
Fast Facts
| Name: | Aredia |
| Generic: | Pamidronate Diodium |
| Manufacturer: | Novartis |
| Date approved: | 1991 |
| Status: | Prescription Only |
| Approved uses: | Treatment of hypocalcaemia, Paget's Disease, and cancer |
| Off-Label uses: | Anti-fracture uses; however, the anti-fracture properties of bisphosphonates such as Aredia, have not been proven |
| Side effects: | Osteonecrosis of the Jaw (ONJ), bone pain, tissue death, loose teeth, sore gums, bone loss, pain and numbness, difficulty breathing, bone fractures, joint disorders, dental problems, kidney problems |
| Related topics: | Fosamax, Actonel, Boniva, Zometa, Bisphosphonates |
Bone Density Drug Aredia May Actually Cause Bone Degeneration
Osteoporosis. Hypocalcemia. Multiple myeloma. Cancer that has metastasized to the bone. These are scary words for patients suffering from bone loss. But patients taking the popular... read more
View the Aredia Main Articles page here
MSN Newsfeeds Related to Aredia
Musculoskeletal pain? Consider patient meds
Swiss stocks - Factors to watch on Jan 8
View the Aredia MSN Newsfeeds page here
News Articles Related to Aredia
View the Aredia News Articles page here
Patents Related to Aredia
Method of treatment of calcium disorders using aminoalkane-diophosphonic acids
View the Aredia Patents page here
Books Related to Aredia
View the Aredia Books page here
